OREXIGEN THERAPEUTICS INC's ticker is and the CUSIP is 686164AB0. A total of 16 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $805,000 | -9.9% | 2,244,000 | 0.0% | 0.09% | -10.3% |
| Q1 2016 | $893,000 | -32.0% | 2,244,000 | 0.0% | 0.10% | -32.6% |
| Q4 2015 | $1,314,000 | -15.5% | 2,244,000 | 0.0% | 0.14% | -23.4% |
| Q3 2015 | $1,555,000 | -44.3% | 2,244,000 | -25.2% | 0.19% | -46.0% |
| Q2 2015 | $2,792,000 | +0.4% | 3,000,000 | +24.2% | 0.35% | +7.7% |
| Q1 2015 | $2,782,000 | – | 2,415,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 10,000,000 | $5,025,000 | 0.78% |
| GLG LLC | 4,960,000 | $2,480,000 | 0.15% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 7,500,000 | $3,000,000,000 | 0.05% |